Stock SPRC SCISPARC LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News SciSparc Ltd.

Equities

SPRC

IL0010951403

Market Closed - Nasdaq
Other stock markets
 03:56:46 2024-06-04 pm EDT 		5-day change 1st Jan Change
0.9441 USD +2.43% Intraday chart for SciSparc Ltd. -14.17% -80.65%
Apr. 11 SciSparc Ltd. signed a merger agreement to acquire remaining stake in Automax Motors Ltd. CI
Apr. 01 SciSparc Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
SciSparc Secures Strategic Advantage with Grant of European Patent
GL
SciSparc to Acquire AutoMax
GL
SciSparc Ltd. signed a merger agreement to acquire remaining stake in Automax Motors Ltd.
CI
SciSparc Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
SciSparc: MitoCareX Unveils Groundbreaking Discovery of Small Molecule Structure in Anti-Cancer Research
GL
SciSparc Granted Another Patent, Strengthening its Core Technology in Canada
GL
SciSparc Granted Another Patent, Strengthening its Core Technology in Canada
AQ
SciSparc Ltd. Receives Another Patent, Strengthening its Core Technology in Canada
CI
SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Trial
GL
SciSparc Ltd. Announces Successfully Dosed the First Patient in Its SCI-210 Clinical Trial At the Soroka Medical Center for Pediatric Patients
CI
SciSparc : MitoCareX Update - Form 6-K
PU
SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule Structure
GL
SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule Structure
AQ
Top Premarket Gainers
MT
SciSparc Announces Enrollment of First Patient for its Clinical Trial for Children with Autism Spectrum Disorder
GL
SciSparc Announces Enrollment of First Patient for its Clinical Trial for Children with Autism Spectrum Disorder
AQ
SciSparc Ltd. Announces Enrollment of First Patient for Its Clinical Trial for Children with Autism Spectrum Disorder
CI
SciSparc Granted Patent for Core Technology in Multiple Jurisdictions in Europe
GL
SciSparc Granted Patent for Core Technology in Multiple Jurisdictions in Europe
AQ
Scisparc Ltd. Granted Patent for Core Technology in Multiple Jurisdictions in Europe
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SPRC Stock
  4. News SciSparc Ltd.